Memorial Sloan Kettering Cancer Center
Dr. Yu is an Associate Attending at MSKCC and Research Director of the Thoracic Oncology Service. She sees patients with thoracic malignancies and oversees the clinical and translational research program for EGFR-mutant lung cancers.
AstraZeneca (Individual(s) Involved: Self): Consultant, Consultant, Grant/Research Support, Grant/Research Support; Black Diamond (Individual(s) Involved: Self): Consultant, Consultant, Grant/Research Support, Grant/Research Support; Blueprint Medicines Corporation (Individual(s) Involved: Self): Consultant, Consultant; Cullinan Oncology (Individual(s) Involved: Self): Consultant, Consultant, Grant/Research Support, Grant/Research Support; Daiichi-Sankyo (Individual(s) Involved: Self): Consultant, Consultant, Grant/Research Support, Grant/Research Support; Erasca (Individual(s) Involved: Self): Grant/Research Support, Grant/Research Support; Janssen Pharmaceuticals (Individual(s) Involved: Self): Consultant, Consultant, Grant/Research Support, Grant/Research Support; Novartis (Individual(s) Involved: Self): Grant/Research Support, Grant/Research Support; Pfizer (Individual(s) Involved: Self): Grant/Research Support, Grant/Research Support
Friday, October 14, 2022
8:00 AM – 9:40 AM
Friday, October 14, 2022
8:35 AM – 8:55 AM
Friday, October 14, 2022
9:10 AM – 9:20 AM
Friday, October 14, 2022
9:20 AM – 9:40 AM